FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method of stimulating posttraumatic spinal cord regeneration. Method of stimulating post-traumatic spinal cord regeneration involves administering an effective amount of a vesicle-based drug prepared from mesenchymal stem cells of adipose tissue.
EFFECT: method described above enables higher effectiveness of stimulating posttraumatic spinal cord regeneration by separate or combined use (application on area of injury in fibrin matrix, intravenous and intrathecal administration), as well as in various post-traumatic periods (acute, intermediate, chronic).
9 cl, 4 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR STIMULATING SPINAL CORD REGENERATION BY MESENCHYMAL STEM CELLS, WHICH ARE INCLUDED IN THE FIBRIN MATRIX | 2016 |
|
RU2650638C1 |
| METHOD OF PRODUCING A MEDICINAL PREPARATION BASED ON HUMAN CELL VESICLES | 2015 |
|
RU2605853C1 |
| METHOD OF BIOFABRICATION OF A TRANSPLANT IN THE FORM OF CELL SPHEROIDS FOR REGENERATIVE TECHNOLOGIES FOR RESTORING A SUBJECT'S CARTILAGE BASED ON THE SUBJECT'S OWN COSTAL CARTILAGE PERICHONDRIUM AND MULTIPOTENT MESENCHYMAL STROMAL BONE MARROW CELLS OF THE SAME SUBJECT | 2022 |
|
RU2800991C2 |
| TREATMENT METHOD FOR AMYOTROPHIC LATERAL SCLEROSIS | 2023 |
|
RU2804196C1 |
| BIOMATERIAL BASED ON CELL-FREE MATRIX PRODUCED BY HUMAN MESENCHYMAL STROMAL CELLS, METHOD FOR PREPARING THEREOF AND METHOD OF USING THEREOF TO STIMULATE REGENERATIVE PROCESSES | 2018 |
|
RU2718907C1 |
| DRUG FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY AND A METHOD FOR ITS TREATMENT | 2021 |
|
RU2769577C1 |
| METHOD OF TREATING POSTTRAUMATIC ENCEPHALOPATHY | 2009 |
|
RU2413523C2 |
| METHOD FOR INCREASING THE PROLIFERATIVE POTENTIAL OF THREE-DIMENSIONAL TUMOR CELL CULTURES | 2021 |
|
RU2782600C1 |
| METHOD FOR OBTAINING OF TWO-COMPONENT PREPARATION FOR TREATMENT OF JOINTS DAMAGE BY LOW-INVASIVE INTRODUCTION INTO JOINT BAG AND PREPARATION OBTAINED BY THIS METHOD | 2016 |
|
RU2638796C1 |
| GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG | 2021 |
|
RU2762855C1 |
